Raymond James Maintains Outperform on Johnson & Johnson, Lowers Price Target to $162

Benzinga · 6d ago
Raymond James analyst Jayson Bedford maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and lowers the price target from $165 to $162.